Amidate (Etomidate Injection, USP) is a sterile, nonpyrogenic solution. Each milliliter contains etomidate, 2 mg, propylene glycol 35% v/v. The pH is 6.0 (4.0 to 7.0).
It is intended for the induction of general anesthesia by intravenous injection.
Etomidate is indicated by intravenous injection for the induction of general anesthesia. When considering use of etomidate, the usefulness of its hemodynamic properties (see CLINICAL PHARMACOLOGY) should be weighed against the high frequency of transient skeletal muscle movements (see ADVERSE REACTIONS).
Intravenous etomidate is also indicated for the supplementation of subpotent anesthetic agents, such as nitrous oxide in oxygen, during maintenance of anesthesia for short operative procedures such as dilation and curettage or cervical conization.
Media Articles Related to Amidate (Etomidate)
Diversity of Anesthesia Procedures in the US by Timing
Source: Medscape Anesthesiology Headlines [2017.01.18]
Does it make sense to use subspecialty anesthesia teams during regular hours but not during weekends or evenings? This study analyzed procedures commonly performed during regular vs. off hours.
Anesthesia & Analgesia
Combining dental, medical procedures may safely limit children's anesthesia exposure
Source: Dentistry News From Medical News Today [2016.10.27]
Children who require both dental and non-dental medical procedures should have them completed under one general anesthesia session whenever possible, which is ideal for both the patient and family...
UW study: Incidence of consciousness during surgery lower than previous estimates
Source: Pain / Anesthetics News From Medical News Today [2016.12.19]
An international study of 260 surgical patients found that, contrary to many previous studies, just more than four percent were conscious of the external world while under general anesthesia but...
Published Studies Related to Amidate (Etomidate)
Dezocine pretreatment prevents myoclonus induced by etomidate: a randomized,
double-blinded controlled trial. 
The aim of this randomized, double-blind, placebo-controlled clinical trial was
to evaluate the effects of dezocine on the incidence and severity of myoclonus
induced by etomidate. Patients (108) were randomly assigned to one of two groups
to receive either 0.1 mg kg(-1) of dezocine (n = 54; Group D) or saline (n = 54;
Group S) intravenously 1 min before 0.3 mg kg(-1) etomidate was given...
Ondansetron reducing pain on injection of etomidate: a controlled randomized
of etomidate... CONCLUSION: This study illustrates that pre-treatment with intravenous
Effect of etomidate versus thiopental on major depressive disorder in
electroconvulsive therapy, a randomized double-blind controlled clinical trial. 
sodium thiopental on the depression symptoms in patients who have received ECT... CONCLUSIONS: In conclusion, etomidate may improve major depressive disorder more
Effect of Etomidate Versus Thiopental on Major Depressive Disorder in Electroconvulsive Therapy, a Randomized Double-Blind Controlled Clinical Trial. [2011.10.06]
BACKGROUND:: Although the therapeutic effect of electroconvulsive therapy (ECT) on major depressive disorder is widely investigated, there is a gap in literature regarding the possible effects of the medications used for induction of anesthesia in ECT. To the best of the authors' knowledge, this study is the first randomized double-blind clinical trial comparing the effect of etomidate and sodium thiopental on the depression symptoms in patients who have received ECT... CONCLUSIONS:: In conclusion, etomidate may improve major depressive disorder more than sodium thiopental in patients who are receiving ECT.
Haemodynamic consequences of etomidate administration in elective cardiac surgery: a randomized double-blinded study. [2011.10]
BACKGROUND: The consequences of inhibition of cortisol synthesis by a single dose of etomidate on subsequent vasopressor drug usage and the duration of relative adrenal insufficiency (RAI) after cardiac surgery are not known... CONCLUSIONS: A single bolus of etomidate blunts the hypothalamic-pituitary-adrenal axis response for more than 24 h in patients undergoing elective cardiac surgery, but this was not associated with an increase in vasopressor requirements.
Clinical Trials Related to Amidate (Etomidate)
Etomidate vs. Midazolam for Sedation During ERCP [Completed]
Recently up-coming drug, etomidate which is a modulator of GABA(gamma-Aminobutyric acid)-A
receptor has been known that it maintains the appropriate sedative levels and affects little
effects on respiratory system.
The investigators are now trying to investigate that etomidate with meperidine combination
regimen is superior to the midazolam with meperidine more effective and less harm on
sedation during the ERCP procedure.
Ketamine Versus Etomidate for Rapid Sequence Intubation [Suspended]
Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions [Completed]
There are multiple retrospective studies detailing the use of etomidate in pediatric
procedural sedation but few to no prospective clinical trials. None have compared etomidate
to ketamine, currently the most commonly used sedative in the emergency department for
pediatric procedural sedation. The investigators propose a randomized, controlled trial
comparing etomidate versus ketamine for procedural sedation for fracture reduction for
children presenting with extremity fracture requiring sedation for reduction. The
investigators hypothesize that etomidate in combination with fentanyl will have similar
reduction of distress and procedural recall as ketamine in combination with midazolam.
Single Dose of Etomidate and Adrenal Cortex [Completed]
we aim to evaluate the effects of single dose of etomidate or use of steroid prior to
etomidate during emergency intubation on hemodynamics and adrenal cortex.
A Dose-response Study of Lidocaine and Etomidate [Completed]